Neogen Corporation Deferred Income Tax Liabilities, Net
Neogen Corporation (NEOG) had Deferred Income Tax Liabilities, Net of $257.60 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-30
- 2026-05-31: Deferred Income Tax Liabilities, Net $257.60M.
- 2026-02-28: Deferred Income Tax Liabilities, Net $269.20M.
- 2025-11-30: Deferred Income Tax Liabilities, Net $273.95M.
- 2025-08-31: Deferred Income Tax Liabilities, Net $277.25M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-05-31 | $257.60M 10-K · filed 2026-07-30 | |
| 2026-02-28 | $269.20M 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $273.95M 10-Q · filed 2026-01-08 | |
| 2025-08-31 | $277.25M 10-Q · filed 2025-10-09 | |
| 2025-05-31 | $280.90M 10-K · filed 2026-07-30 | $280.91M 10-K · filed 2025-07-30 |
| 2025-02-28 | $301.05M 10-Q · filed 2025-04-09 | |
| 2024-11-30 | $302.40M 10-Q · filed 2025-01-15 | |
| 2024-08-31 | $317.57M 10-Q · filed 2024-10-10 | |
| 2024-05-31 | $326.72M 10-K · filed 2025-07-30 | |
| 2024-02-29 | $353.85M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $355.00M 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $354.79M 10-Q · filed 2023-10-10 | |
| 2023-05-31 | $353.43M 10-K · filed 2024-07-30 | |
| 2023-02-28 | $362.63M 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $364.25M 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $15.95M 10-Q · filed 2022-09-30 | |
| 2022-05-31 | $17.01M 10-K · filed 2023-08-15 | |
| 2022-02-28 | $21.20M 10-Q · filed 2022-04-01 | |
| 2021-11-30 | $21.83M 10-Q · filed 2021-12-30 | |
| 2021-08-31 | $21.83M 10-Q · filed 2021-09-30 | |
| 2021-05-31 | $21.92M 10-K · filed 2022-07-27 | |
| 2021-02-28 | $21.28M 10-Q · filed 2021-03-31 | |
| 2020-11-30 | $18.39M 10-Q · filed 2020-12-29 | |
| 2020-08-31 | $18.31M 10-Q · filed 2020-09-30 | |
| 2020-05-31 | $18.13M 10-K · filed 2021-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |